Recruiting

Sexual Health Education During Pregnancy

This experimental, randomized controlled, single-blind study includes intervention and control groups. Pregnant women between 16 and 20 weeks of gestation who meet the inclusion criteria and agree to participate will be included in the study. Pregnant women will be randomly assigned to groups. Pre-test data will be collected from both groups. The intervention group will receive sexual counseling training in two sessions, face-to-face and in groups, until week 22. Second test data will be collected after week 37…

ClinicalTrials.gov IDNCT07517549
PhaseNA
Enrollment70
SponsorOrdu University
Age18 Years
SexFEMALE
I'm interested View official listing

Conditions studied

Sexuality, Depression, Pregnancy Related

About this study

This experimental, randomized controlled, single-blind study includes intervention and control groups. Pregnant women between 16 and 20 weeks of gestation who meet the inclusion criteria and agree to participate will be included in the study. Pregnant women will be randomly assigned to groups. Pre-test data will be collected from both groups. The intervention group will receive sexual counseling training in two sessions, face-to-face and in groups, until week 22. Second test data will be collected after week 37 (before delivery), and final test data will be collected three months after delivery. This study is expected to have a significant impact on women's lives, as this topic is considered taboo in our country, leading to a lack of open discussion and the prevalence of misconceptions and false beliefs (sexual myths).

Interventions

Primary outcomes

Eligibility information

Eligibility criteria; * Volunteers to participate in the research, * primary school graduate, * Pregnant between 16-20 weeks * Having a single pregnancy, * Able to understand and speak Turkish, * Living with his wife for the past four weeks, * No threat of abortion or premature birth, Exclusion Criteria: * Someone who has been diagnosed with a chronic illness, * People with diagnosed physical and mental health issues, * Someone who has been diagnosed with a psychological disorder, * Having a high-risk pregnancy, * Having an IVF pregnancy, * Low threat, * Anyone who has been diagnosed with any sexually transmitted disease, either themselves or in their partner, * Those using medications that may negatively affect sexual function, * including antipsychotics, antihypertensives, phenobarbital, and opioids.

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-03.